Treosulfan, fludarabine and cytarabine (FLAT) myeloablative conditioning for autologous stem cell transplantation in elderly patients with acute myeloid leukemia in first complete remission

被引：0
|
作者：
Bernardi, Massimo [1 ]
Pavesi, Francesca [1 ]
Messina, Carlo [1 ]
Lorentino, Francesca [1 ]
Peccatori, Jacopo [1 ]
Assanelli, Andrea [1 ]
Vago, Luca [1 ]
Gentner, Bernhard [1 ]
Milani, Raffaella [1 ]
Casirati, Gabriele [1 ]
Sala, Elisa [1 ]
Mastaglio, Sara [1 ]
Ciceri, Fabio [1 ]
机构：
[1] Ist Sci San Raffaele, Milan, Italy
来源：
BONE MARROW TRANSPLANTATION | 2018年 / 53卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P061
引用
收藏
页码：192 / 192
页数：1
相关论文
共 50 条
  • [41] Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of acute myeloid leukemia relapsing after autologous stem cell transplantation
    F. Ferrara
    L. Melillo
    M. Montillo
    F. Leoni
    A. Pinto
    G. Mele
    S. Mirto
    Annals of Hematology, 1999, 78 : 380 - 384
  • [42] Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMT
    Gesine Bug
    Myriam Labopin
    Riitta Niittyvuopio
    Matthias Stelljes
    Hans Christian Reinhardt
    Inken Hilgendorf
    Nicolaus Kröger
    Ain Kaare
    Wolfgang Bethge
    Kerstin Schäfer-Eckart
    Mareike Verbeek
    Stephan Mielke
    Kristina Carlson
    Ali Bazarbachi
    Alexandros Spyridonidis
    Bipin N. Savani
    Arnon Nagler
    Mohamad Mohty
    Bone Marrow Transplantation, 2023, 58 : 710 - 716
  • [43] Myeloablative Chemo-Conditioning for First Hematopoietic STEM CELL Transplantation in Children with ACUTE Lymphoblastic Leukemia in First or Second Remission
    Peters, Christina
    Dalle, Jean-Hugues
    Graphakos, Stelios
    Sedlacek, Petr
    Campos, Antonio
    Yesilipek, M. Akif
    Wachowiak, Jacek
    Lankester, Arjan C.
    Pession, Andrea
    Hamidieh, Amir Ali
    Ifversen, Marianne
    Buechner, Jochen
    Krivan, Gergely
    Fagioli, Franca
    Dalissier, Arnaud
    Labopin, Myriam
    Bader, Peter
    BLOOD, 2014, 124 (21)
  • [44] Comparison of autologous stem cell transplantation versus haploidentical donor stem cell transplantation for favorable- and intermediate-risk acute myeloid leukemia patients in first complete remission
    Chen, Jia
    Yang, Lingyi
    Fan, Yi
    Xu, Yang
    Han, Yue
    Tang, Xiaowen
    Qiu, Huiying
    Fu, Chengcheng
    Miao, Miao
    Chen, Feng
    Wu, Depei
    BONE MARROW TRANSPLANTATION, 2018, 53 : 156 - 157
  • [45] Comparison of Autologous Stem Cell Transplantation versus Haploidentical Donor Stem Cell Transplantation for Favorable- and Intermediate-Risk Acute Myeloid Leukemia Patients in First Complete Remission
    Chen, Jia
    Yang, Lingyi
    Fan, Yi
    Xu, Yang
    Han, Yue
    Tang, Xiaowen
    Qiu, Huiying
    Fu, Chengcheng
    Miao, Miao
    Chen, Feng
    Wu, Depei
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (04) : 779 - 788
  • [46] High-dose idarubicin plus busulfan as conditioning regimen to autologous stem cell transplantation: Promising post-remission therapy for acute myeloid leukemia in first complete remission?
    Ming Hong
    Kou-Rong Miao
    Run Zhang
    Hua Lu
    Peng Liu
    Wei Xu
    Li-Juan Chen
    Su-Jiang Zhang
    Han-Xin Wu
    Hong-Xia Qiu
    Jian-Yong Li
    Si-Xuan Qian
    Medical Oncology, 2014, 31
  • [47] High-dose idarubicin plus busulfan as conditioning regimen to autologous stem cell transplantation: Promising post-remission therapy for acute myeloid leukemia in first complete remission?
    Hong, Ming
    Miao, Kou-Rong
    Zhang, Run
    Lu, Hua
    Liu, Peng
    Xu, Wei
    Chen, Li-Juan
    Zhang, Su-Jiang
    Wu, Han-Xin
    Qiu, Hong-Xia
    Li, Jian-Yong
    Qian, Si-Xuan
    MEDICAL ONCOLOGY, 2014, 31 (06)
  • [48] Allogeneic hematopoietic stem cell transplantation using reduced intensity conditioning regimen for patients with acute myeloid leukemia not in complete remission
    Shimomura, Yoshimitsu
    Kitamura, Tetsuhisa
    Yanada, Masamitsu
    Mizuno, Shohei
    Kondo, Tadakazu
    Yoshihara, Satoshi
    Tanaka, Masatsugu
    Inai, Kazuki
    Katayama, Yuta
    Onizuka, Makoto
    Fukuda, Takahiro
    Nakamae, Hirohisa
    Kurokawa, Mineo
    Yano, Shingo
    Nara, Miho
    Masuko, Masayoshi
    Miyakoshi, Shigesaburo
    Eto, Tetsuya
    Yoshimitsu, Makoto
    Ishimaru, Fumihiko
    Kanda, Junya
    Atsuta, Yoshiko
    Konuma, Takaaki
    CYTOTHERAPY, 2025, 27 (03) : 316 - 323
  • [49] Low-toxic myeloablative conditioning regimen in haploidentical hematopietic stem cell transplantation for elderly patients with acute myeloid leukemia.
    Aristei, Cynthia
    Lancellotta, Valentina
    Carotti, Alessandra
    Zucchetti, Claudio
    Pierini, Antonio
    Saldi, Simonetta
    Ruggeri, Loredana
    Amico, Lucia
    Iacco, Martina
    Velardi, Andrea
    Martelli, Massimo Fabrizio
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [50] REDUCED INTENSITY VERSUS STANDARD MYELOABLATIVE CONDITIONING IN PATIENTS WITH ACUTE MYELOID LEUKEMIA IN SECOND COMPLETE REMISSION
    Terwey, T. H.
    Hemmati, P. G.
    Vuong, L. G.
    le Coutre, P.
    Massenkeil, G.
    Doerken, B.
    Arnold, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S308 - S308
12345